- Institute of Systems Medicine (ISM)
Yuting MA received her PhD degree in Immunology from Université Paris Sud 11, followed by postdoctoral trainings in INSERM, Institut Gustave Roussy, and Cordelier Research Center in Paris. To extend the pursuit of research in stress response and tumor immunology, she established a laboratory in Institute of Systems Medicine (ISM, Suzhou), Chinese Academy of Medical Sciences in 2015. She is the current Associate Dean of ISM and Chief of Immunology Platform. Her continuous endeavors on these aspects led to over 50 highly-cited publications (>7200 citations) in prestigious scientific journals (Nat Med, Science, Nat Rev Immunol, Nat Immunol, Immunity…), as well as the identification of novel therapeutic targets and prognostic/predictive biomarkers for cancer patients. She is listed as one of the Top 2% Scientists Worldwide 2022 by Stanford University. Yuting is the principal investigator of several important research grants (Innovation 2030 Major Project of China, National Leading Innovative Talent in Science and Technology, National Natural Science Funds for Outstanding Young Scholars, CAMS Initiative for Innovative Medicine…). She is the laureate of Chinese Young Women Scientist Award and Chinese Young Scientist Award for Cancer Research. Besides, she serves as an associated editor of Cancer Immunity and Immunotherapy, Frontiers in Immunology, and Frontiers in Oncology. She is also an editorial board member of Communications Biology, Immunotherapy Advances, and Current Research in Immunology.
Her research focus is to decipher:
- How different modalities of cellular stress and demise (autophagy, apoptosis, necroptosis, pyroptosis, ferroptosis, ER stress…) modulate the immunogenicity of tumor cells, tumor immune microenvironment and anti-tumor immunity.
- How psychological stress reshapes the neuroendocrine-metabolism-immune-microbiota networks, which sculpture local and systemic immune responses against cancer and infection.